Related Experiment Video
Updated: Jun 24, 2026
06:13
Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018
Chronic rhinosinusitis with and without nasal polyps: what is the difference?
Wouter Huvenne1, Nicholas van Bruaene, Nan Zhang
1Upper Airway Research Laboratory, Department of Oto-Rhino-Laryngology, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium. Wouter.Huvenne@UGent.be
Current Allergy and Asthma Reports
|April 8, 2009
Summary
Chronic rhinosinusitis (CRS) is a complex sinus disease. New markers help classify CRS, enabling targeted diagnostics and therapies for distinct disease subtypes.
Area of Science:
- Immunology
- Pathophysiology
- Otolaryngology
Background:
- Chronic rhinosinusitis (CRS) represents a heterogeneous group of chronic sinus diseases with varying underlying pathomechanisms.
- Recent advancements in understanding CRS have led to the development of disease markers for improved classification.
- Identifying distinct disease entities within CRS is crucial for advancing diagnostic and therapeutic approaches.
Purpose of the Study:
- To explore the pathomechanisms of chronic rhinosinusitis (CRS).
- To introduce and utilize disease markers for classifying distinct CRS entities.
- To pave the way for novel, targeted diagnostic and therapeutic strategies for specific CRS types.
Main Methods:
- Evaluation of inflammatory cell profiles in CRS patients.
- Differentiation of T-effector cell subsets.
- Characterization of tissue remodeling processes (e.g., fibrosis, edema).
- Analysis of innate and adaptive immunity products (e.g., Toll-like receptors, immunoglobulins).
Main Results:
- Distinct disease entities within chronic rhinosinusitis (CRS) can be identified using various biological markers.
- Inflammatory cell profiles and immune responses vary among different CRS subtypes.
- Remodeling processes like fibrosis and edema are key features differentiating CRS entities.
Conclusions:
- Disease differentiation in chronic rhinosinusitis (CRS) enhances understanding of its pathophysiology.
- Specific biomarkers facilitate the classification of CRS into distinct, clinically relevant entities.
- Targeted diagnostic and therapeutic strategies can be developed based on identified CRS disease entities.
Related Concept Videos
01:23Chronic Pharyngitis
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation